用新型选择性5-羟色胺2（5-HT2）受体拮抗剂酮色林治疗高血压。
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.
作者信息
Wenting G J, Man in 't Veld A J, Woittiez A J, Boomsma F, Schalekamp M A
出版信息
Br Med J (Clin Res Ed). 1982 Feb 20;284(6315):537-9. doi: 10.1136/bmj.284.6315.537.
Abstract
The new selective 5-HT2 receptor blocking agent ketanserin was given in a dose of 10 mg intravenously to 12 patients with essential hypertension. It caused a distinct fall in supine systemic arterial, right atrial, pulmonary artery, and pulmonary capillary "wedge" pressures. Cardiac output, renal blood flow, and glomerular filtration rate showed no persistent changes. Thus 5-HT2 receptor blockade caused dilatation of both resistance and capacitance vessels and of the renal vascular bed. Heart rate and plasma concentrations of renin and noradrenaline rose after ketanserin. These data suggest that 5-HT may have a role in maintaining high blood pressure.
摘要
给12例原发性高血压患者静脉注射10毫克新型选择性5-羟色胺2（5-HT2）受体阻滞剂酮色林。它使仰卧位时的体循环动脉压、右心房压、肺动脉压和肺毛细血管“楔压”明显下降。心输出量、肾血流量和肾小球滤过率未显示持续变化。因此，5-HT2受体阻滞导致阻力血管、容量血管以及肾血管床扩张。注射酮色林后心率、肾素和去甲肾上腺素的血浆浓度升高。这些数据表明5-羟色胺可能在维持高血压中起作用。
相似文献
1
Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist.用新型选择性5-羟色胺2（5-HT2）受体拮抗剂酮色林治疗高血压。
Br Med J (Clin Res Ed). 1982 Feb 20;284(6315):537-9. doi: 10.1136/bmj.284.6315.537.
2
5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.5-羟色胺、α-肾上腺素能受体与血压。酮色林在原发性高血压和自主神经功能不全中的作用。
Hypertension. 1984 Jan-Feb;6(1):100-9. doi: 10.1161/01.hyp.6.1.100.
3
Ketanserin: a possible tool for studying the role of serotonin in hypertension.酮色林：一种研究5-羟色胺在高血压中作用的可能工具。
J Cardiovasc Pharmacol. 1985;7 Suppl 7:S130-6.
4
Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery.酮色林在冠状动脉搭桥手术治疗高血压中的心血管效应。
J Cardiovasc Pharmacol. 1986 Jan-Feb;8(1):109-15. doi: 10.1097/00005344-198601000-00017.
5
5-HT2-receptor blockade in the treatment of heart failure. A preliminary study.5-羟色胺2受体阻断剂治疗心力衰竭的初步研究
Lancet. 1981 May 30;1(8231):1186-8. doi: 10.1016/s0140-6736(81)92352-7.
6
Controlled trial of ketanserin in hypertension.酮色林治疗高血压的对照试验。
Br J Clin Pharmacol. 1985 Jul;20(1):37-40. doi: 10.1111/j.1365-2125.1985.tb02795.x.
7
Effects of serotonin on the cardiopulmonary circulatory system with and without 5-HT2-receptor blockade by ketanserin.血清素对心肺循环系统的影响，以及酮色林对5-HT2受体的阻断作用。
J Cardiovasc Pharmacol. 1985;7 Suppl 7:S64-6. doi: 10.1097/00005344-198500077-00019.
8
Ketanserin, a serotonin antagonist. Administration in patients with acute respiratory failure.酮色林，一种5-羟色胺拮抗剂。用于急性呼吸衰竭患者。
Chest. 1984 Apr;85(4):510-3. doi: 10.1378/chest.85.4.510.
9
Long-term effects on central haemodynamics and body fluid volumes of ketanserin in essential hypertension studies at rest and during dynamic exercise.酮色林对原发性高血压患者静息及动态运动时中心血流动力学和体液容量的长期影响研究。
J Hypertens. 1983 Dec;1(4):405-12. doi: 10.1097/00004872-198312000-00014.
引用本文的文献
1
Serotonin and blood pressure regulation.血清素与血压调节。
Pharmacol Rev. 2012 Apr;64(2):359-88. doi: 10.1124/pr.111.004697. Epub 2012 Mar 8.
2
5-hydroxtryptamine receptors in systemic hypertension: an arterial focus.5-羟色胺受体与系统性高血压：动脉焦点
Cardiovasc Ther. 2011 Feb;29(1):54-67. doi: 10.1111/j.1755-5922.2010.00173.x.
3
Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.使用5-羟色胺2受体拮抗剂酮色林治疗雷诺现象。
Br Med J (Clin Res Ed). 1982 Oct 16;285(6348):1069-71. doi: 10.1136/bmj.285.6348.1069.
4
Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.5-羟色胺2型受体拮抗剂酮色林对原发性高血压患者血压、肾素-血管紧张素系统及交感-肾上腺功能的影响
Br J Clin Pharmacol. 1984 Mar;17(3):309-16. doi: 10.1111/j.1365-2125.1984.tb02346.x.
5
Acute effects of ketanserin on left ventricular function, metabolism and coronary blood flow.酮色林对左心室功能、代谢及冠状动脉血流的急性影响。
Br J Clin Pharmacol. 1984 Mar;17(3):301-7. doi: 10.1111/j.1365-2125.1984.tb02345.x.
6
Effects of LM 5008, a selective inhibitor of 5-hydroxytryptamine uptake, on blood pressure and responses to sympathomimetic amines.5-羟色胺摄取选择性抑制剂LM 5008对血压及对拟交感胺反应的影响。
Br J Pharmacol. 1983 Aug;79(4):915-22. doi: 10.1111/j.1476-5381.1983.tb10536.x.
7
Ketanserin in essential hypertension: effects during rest and exercise.酮色林治疗原发性高血压：静息和运动时的效果
Eur J Clin Pharmacol. 1983;25(3):307-12. doi: 10.1007/BF01037939.
8
The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man.5-羟色胺拮抗剂酮色林对正常人体血压、肾素-血管紧张素系统及交感肾上腺功能的影响。
Br J Clin Pharmacol. 1983 Sep;16(3):305-11. doi: 10.1111/j.1365-2125.1983.tb02166.x.
9
Pharmacokinetics of ketanserin in man.酮色林在人体中的药代动力学。
Eur J Clin Pharmacol. 1983;25(1):73-6. doi: 10.1007/BF00544018.
10
Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension.酮色林，一种新型5-羟色胺拮抗剂：用于原发性高血压的单一疗法。
Br J Clin Pharmacol. 1983 Aug;16(2):121-5. doi: 10.1111/j.1365-2125.1983.tb04974.x.
本文引用的文献
1
Supersensitivity of atherosclerotic rabbit aorta to ergonovine. Mediation by a serotonergic mechanism.动脉粥样硬化兔主动脉对麦角新碱的超敏反应。由5-羟色胺能机制介导。
J Clin Invest. 1980 Aug;66(2):306-13. doi: 10.1172/JCI109858.
2
Review of the role of the central serotonergic neuronal system in blood pressure regulation.中枢5-羟色胺能神经元系统在血压调节中的作用综述。
Hypertension. 1980 May-Jun;2(3):243-55. doi: 10.1161/01.hyp.2.3.243.
3
Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.新型5-羟色胺2受体拮抗剂R 41 468的受体结合情况
Life Sci. 1981 Mar 2;28(9):1015-22. doi: 10.1016/0024-3205(81)90747-5.
4
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors.酮色林（R 41 468）的血管效应，一种新型5-羟色胺2（5-HT2）血清素能受体拮抗剂。
J Pharmacol Exp Ther. 1981 Jul;218(1):217-30.
5
5-HT2-receptor blockade in the treatment of heart failure. A preliminary study.5-羟色胺2受体阻断剂治疗心力衰竭的初步研究
Lancet. 1981 May 30;1(8231):1186-8. doi: 10.1016/s0140-6736(81)92352-7.
6
Acute blood-pressure-lowering effect of ketanserin.酮色林的急性降压作用。
Lancet. 1981 May 23;1(8230):1161-2. doi: 10.1016/s0140-6736(81)92331-x.
7
Abnormal renal haemodynamics and renin suppression in hypertensive patients.高血压患者的肾血流动力学异常与肾素抑制
Clin Sci. 1970 Jan;38(1):101-10. doi: 10.1042/cs0380101.
8
A sensitive radioenzymatic assay for norepinephrine in tissues and plasma.一种用于检测组织和血浆中去甲肾上腺素的灵敏放射酶分析法。
Life Sci. 1975 Feb 1;16(3):375-84. doi: 10.1016/0024-3205(75)90258-1.
9
10
Inactive renin in human plasma.人血浆中的无活性肾素。
Lancet. 1976 Sep 4;1(7984):496-9. doi: 10.1016/s0140-6736(76)90791-1.
Zotero 插件